Complete Response of Metastatic Melanoma to Second Line Chemotherapy with Paclitaxel and Carboplatin - Case Report

Authors

  • Krešimir Tomić Clinic of Oncology, University Clinical Hospital Mostar, Mostar
  • Ivana Tica Sedlar Clinic of Oncology, University Clinical Hospital Mostar, Mostar
  • Gordana Berić Jozić Clinic of Oncology, University Clinical Hospital Mostar, Mostar
  • Inga Marijanović Clinic of Oncology, University Clinical Hospital Mostar, Mostar
  • Blanka Lukić Clinic of Oncology, University Clinical Hospital Mostar, Mostar
  • Dragana Miletić Clinic of Oncology, University Clinical Hospital Mostar, Mostar
  • Ana Puljić Ćuk Clinic of Oncology, University Clinical Hospital Mostar, Mostar

DOI:

https://doi.org/10.5644/ama2006-124.217

Keywords:

Metastatic melanoma, Chemotherapy, Second line

Abstract

Objective. We present a patient with metastatic melanoma who had a complete response to second line chemotherapy with paclitaxel and carboplatin.

Case report. Metastatic melanoma is an aggressive cancer with poor prognosis and 10 year survival less than 10%. We present a patient with metastatic melanoma who had a complete response to second line chemotherapy with paclitaxel and carboplatin.

Conclusion. Second line chemotherapy with paclitaxel and carboplatin in the treatment of metastatic melanoma may yield effective results.

Ðorđe Mihajlović (1875-1919), “Old Tuzla” (1918)

Downloads

Published

25.06.2018

Issue

Vol. 47 No. 1 (2018)

Section

Case Report

How to Cite

Complete Response of Metastatic Melanoma to Second Line Chemotherapy with Paclitaxel and Carboplatin - Case Report. (2018). Acta Medica Academica, 47(1), 82-87. https://doi.org/10.5644/ama2006-124.217

Most read articles by the same author(s)